Ernst & Young Global Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8822
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ernst & Young Global Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Ernst & Young Global Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ernst & Young Global Limited (EYG) is a provider of and a wide range of professional services, including assurance, tax, transaction advisory services, and advisory services. It also offers a portfolio of specialty services, including climate change and sustainability services, family business services, Japanese business services, China overseas investment network, and global business network, among others. EYG invests in advancing its client technology and innovation. The company serves audit, non-audit, and various other clientele in the Americas; Europe, Middle East, Africa; India; Asia-Pacific; and Japan. EYG is headquartered in London, the UK.

Scope

- Detailed information on Ernst & Young Global Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ernst & Young Global Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Ernst & Young Global Ltd including a breakdown and examination of key business segments
- Intelligence on Ernst & Young Global Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ernst & Young Global Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ernst & Young Global Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ernst & Young Global Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ernst & Young Global Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ernst & Young Global Ltd: Company Overview 9
Ernst & Young Global Ltd: Overview and Key Facts 9
Ernst & Young Global Ltd: Overview 9
Ernst & Young Global Ltd: Key Facts 9
Ernst & Young Global Ltd: Key Employees 10
Ernst & Young Global Ltd: Key Employee Biographies 12
Ernst & Young Global Ltd: Major Products and Services 16
Ernst & Young Global Ltd: Company History 18
Ernst & Young Global Ltd: Management Statement 24
Ernst & Young Global Ltd: Locations and Subsidiaries 25
Ernst & Young Global Ltd: Key Competitors 27
Ernst & Young Global Ltd: Company Analysis 28
Ernst & Young Global Ltd: Business Description 28
Ernst & Young Global Ltd: SWOT Analysis 30
Ernst & Young Global Ltd: SWOT Overview 30
Ernst & Young Global Ltd: Strengths 30
Ernst & Young Global Ltd: Weaknesses 31
Ernst & Young Global Ltd: Opportunities 32
Ernst & Young Global Ltd: Threats 33
Ernst & Young Global Ltd: Corporate Financial Deals Activity 34
Ernst & Young Global Ltd: Financial Deals Overview 34
Ernst & Young Global Ltd: Targets and Partners 36
Ernst & Young Global Ltd: Top Deals 2014 – 2018YTD* 38
Ernst & Young Global Ltd: Advisors 39
Ernst & Young Global Ltd: Top Legal Advisors 39
Ernst & Young Global Ltd: Mergers and Acquisitions 40
Ernst & Young Global Ltd: Partnership 41
Ernst & Young Global Ltd: Recent Developments 42
Ernst & Young Global Ltd: News and Events Summary 42
Ernst & Young Global Ltd: Business Expansion 45
Ernst & Young Global Ltd: Contracts 45
Ernst & Young Global Ltd: Corporate Governance 46
Ernst & Young Global Ltd: Financial Deals 47
Ernst & Young Global Ltd: Regulatory and Legal Events 47
Ernst & Young Global Ltd: Strategy and Operations 47
Appendix 49
Contact Us 49
Methodology 49
About MarketLine 50

List of Tables
Table 1: Ernst & Young Global Ltd: Key Facts
Table 2: Ernst & Young Global Ltd: Key Employees
Table 3: Ernst & Young Global Ltd: Company History
Table 4: Ernst & Young Global Ltd: Locations and Subsidiaries
Table 5: Ernst & Young Global Ltd: Key Competitors
Table 6: Ernst & Young Global Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ernst & Young Global Ltd: M&A Activity by Geography (TTM*)
Table 8: Ernst & Young Global Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Ernst & Young Global Ltd: Targets and Partners
Table 10: Ernst & Young Global Ltd: Top Deals 2014 - 2018YTD*
Table 11: Ernst & Young Global Ltd: Legal Advisor Ranking by Value (US$m)
Table 12: Ernst & Young Global Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Ernst & Young Global Ltd: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Ernst & Young Global Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Ernst & Young Global Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Ernst & Young Global Ltd: News and Events Summary
Table 17: Ernst & Young Global Ltd: Business Expansion
Table 18: Ernst & Young Global Ltd: Contracts
Table 19: Ernst & Young Global Ltd: Corporate Governance
Table 20: Ernst & Young Global Ltd: Financial Deals
Table 21: Ernst & Young Global Ltd: Regulatory and Legal Events
Table 22: Ernst & Young Global Ltd: Strategy and Operations

List of Figures
Figure 1: Ernst & Young Global Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ernst & Young Global Ltd: M&A Activity by Geography (TTM*)
Figure 3: Ernst & Young Global Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Ernst & Young Global Ltd: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Ernst & Young Global Ltd: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Ernst & Young Global Ltd: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Ernst & Young Global Ltd: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ernst & Young Global Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KDH Defense Systems, Inc.:企業の戦略・SWOT・財務情報
    KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ergomed Plc(製薬・医療分野):企業M&A動向
    Summary Ergomed Plc (Ergomed) is a specialized international clinical development company. The company offers contract clinical research and co-development partnerships to biotechnology and pharmaceutical companies worldwide in the fields of neurology, oncology and immunology. The company offers cli …
  • Network Rail Limited:企業の戦略・SWOT・財務分析
    SummaryNetwork Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Nikkiso Co., Ltd. (6376):企業のM&A・提携動向(医療機器分野)
    Summary Nikkiso Co., Ltd. (Nikkiso) is a diversified company, which develops, manufactures and markets medical equipment and industrial instruments. Nikkiso classifies its products into five categories: pumps, sampling systems and chemical feed systems; particle size characterization; equipment for …
  • Great Western Oil & Gas Company, LLC:企業のM&A・提携動向(石油・ガス分野)
    Summary Great Western Oil & Gas Company, LLC (GWOG), a subsidiary of The Broe Group is an oil and gas company that offers exploration and production of oil and gas properties. The company operates through developmental drilling, and corporate and property acquisition operations. Its core area of ope …
  • AstraZeneca KK-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca KK (AstraZeneca), a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dis …
  • Questcor Pharmaceuticals, Inc.の企業概要及び財務/SWOT分析
    Questcor Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Questcor Pharmaceuticals, Inc. annual and quarterly forecasts made by stock market experts. The …
  • Tyrian Diagnostics Limited (TDX):企業の財務及び戦略的SWOT分析
    Summary Tyrian Diagnostics Limited (Tyrian Diagnostics) is a diagnostic company that manufactures, develops and distributes diagnostics for clinical and non-clinical applications. The company offers a proprietary point of care diagnostics platform such as diagnostiQTM. It also develops various solut …
  • Impatients NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Impatients NV (Impatients), doing business as myTomorrows is a provider of drugs development and diagnostic testing services. The company’s services include turnkey solutions, global distribution solutions, early access programs, uniform information on medical conditions, and drugs developme …
  • Flowonix Medical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Flowonix Medical, Inc. (Flowonix) is a medical device company. The company manufactures and distributes implantable pumps that are capable of delivering a wide array of therapeutic drugs for the treatment of chronic diseases and conditions. Its products include prometra pump, catheter, and a …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Relief Therapeutics Holding AG (RLF):企業財務及び戦略的SWOT分析
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company which focuses on the clinical development of peptides and proteins of natural or engineered origin. Its pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 (a …
  • Pint Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a pharmaceutical company which develops, manufactures and markets originator drugs focused in rare disease, oncology and specialty pharma. The company offers wide range of products in the form of tablets, inject …
  • Offshore Oil Engineering Co Ltd (600583):石油・ガス:M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Empire Energy Group Limited (EEG):企業財務及び戦略的SWOT分析
    Summary Empire Energy Group Limited (EEGL), formerly Imperial Corporation Limited is oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. …
  • Tractebel Energia S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tractebel Energia S.A. Mergers …
  • Nimbus Therapeutics LLC:企業のM&A・提携動向(医療分野)
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly known as Nimbus Discovery, LLC is a biotechnology company that develops medicines for critical diseases such as cancer, metabolic disease and immune-inflammatory disorders. The company offers a diverse pipeline of novel small molecule p …
  • CapitaLand Limited:企業のM&A・事業提携・投資動向
    CapitaLand Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CapitaLand Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bhansali Engineering Polymers Limited (BEPL):企業財務及び戦略的SWOT分析
    Summary Bhansali Engineering Polymers Limited (BEPL) is a petrochemical company that manufactures and markets acrylonitrile butadiene styrene. The company offers products which include general ABS, ABS-GF or SAN-GF, extrusion ABS, flame retardant ABS, PC or ABS alloys, PMMA-ABS, PVC modifier, SAN re …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆